October 26, 2022
The University of Cincinnati's Kelly Dobos was featured in a Washington Post article about the recent recall of more than a dozen dry shampoos due to the possibility they contain “elevated levels” of benzene.
October 25, 2022
National media outlets highlighted the results of the first-in-human trial of FLASH radiotherapy, led by University of Cincinnati Cancer Center researchers.
October 24, 2022
University of Cincinnati researchers presented results from the first-in-human trial of FLASH radiotherapy at the ASTRO 2022 annual meeting, with data suggesting FLASH may hold promise as a potential treatment for tough-to-kill tumors.
October 17, 2022
Local media covered the 13th annual Walk Ahead for a Brain Tumor Cure event, which raised more than $200,000 for the UC Brain Tumor Center.
October 14, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, joined the Five to Thrive Live podcast to discuss "Humanizing Brain Tumors."
October 13, 2022
The University of Cincinnati's Jeffrey Strawn, MD, is senior author of a new editorial in JAMA discussing new recommendations that children and adolescents ages 8 to 18 should be screened for anxiety disorders.
October 12, 2022
The University of Cincinnati's Pooja Khatri joined NBC News' Meet the Press Now to discuss stroke recovery in light of Pennsylvania Senate candidate John Fetterman campaigning while recovering from a stroke.
October 10, 2022
Local 12 News and 55KRC's Simply Medicine podcast highlighted the the University of Cincinnati Gardner Neuroscience Institute's transformation into a Learning Health System, beginning with work in epilepsy.
October 6, 2022
The University of Cincinnati Brain Tumor Center (BTC) held its second-annual Clinical Research Retreat on Sept. 30, bringing researchers from around the country together to discuss advancements in neuro-oncology clinical research.
October 6, 2022
U.S. News & World Report highlighted recent research from the University of Cincinnati that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.